Clinical Trials Study
Copyright
©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Mar 7, 2017; 23(9): 1645-1656
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1645
Table 1 Demographics and characteristics of patients, defects, and over-the-scope clips
Characteristics Details Total patients (n = 58) Age, median (range), yr 77 (37-98) Indications, n Refractory bleeding 18 Ulcer (peptic, Behçet's, anastomosis) 12 Mallory-Weiss tear 1 Diverticula 2 Post-endoscopic resection 3 Leaks 28 Peptic ulcer 3 Boerhaave 1 Iatrogenic (ESD) 16 Iatrogenic (ERCP) 2 Iatrogenic (surgery) 4 Iatrogenic (other) 2 Fistula 12 PEG 6 Rectum-bladder 1 Rectum-pelvis 2 Gastric tube-trachea 1 Gastric-pseudopancreatic cyst 1 Colon-gallbladder 1 Location, n Esophagus 3 Stomach 28 Duodenum 13 Small intestine 2 Colon 12 Maximum defect size (D) mm, n D ≤ 10 25 10 < D ≤ 20 9 20 < D 24 Median (range), mm 15 (3-50) Duration since onset to OTSC placement, n Immediate ≤ 1 d 25 1 < Acute ≤ 7 d 11 Chronic > 7 d 22 Suction method into the applicator cap Simple suction 14 Twin Grasper (TG) assist 42 Anchor assist 2 The number of OTSC deployments, n 0 21 1 39 2 12 3 5
Table 2 Results of major outcomes
Outcomes Total patients (n = 58) Technical success rate, % (95%CI) 89.7 (81.0-98.4) Clinical success rate, % (95%CI) 84.5 (74.3-94.7) Complications, n (% ) 1 (1.8) in 56 cases used The procedure time, median (range), min 8 (1-36) in 52 successful cases
Table 3 Results of the technical and clinical success rates for each parameter
Parameters Total patients (n = 58) Technical success rate Clinical success rate Indications Refractory bleeding 88.9 (16/18) 83.3 (15/18) Leak 89.3 (25/28) 85.7 (24/28) Fistula 91.7 (11/12) 83.3 (10/12) Location Upper GI tract 86.4(38/44) 81.8 (36/44) Lower GI tract 100 (14/14) 92.9 (13/14) Maximum defect size (D), mm D ≤ 10 96 (24/25) 84 (21/25) 10 < D ≤ 20 88.9 (8/9) 88.9 (8/9) 20 < D 83.3 (20/24) 83.3 (20/24) Duration since onset, % (n ) Immediate ≤ 1 d 96 (24/25) 96 (24/25) 1 < Acute ≤ 7 d 90.9 (10/11) 81.8 (9/11) Chronic > 7 d 81.8 (18/22) 72.7 (16/22) Suction method into the applicator cap Simple suction (SS) 100 (14/14) 78.6 (11/14) Twin Grasper (TG) Anchor assist 88.1 (37/42) 50 (1/2) 88.1 (37/42) 50 (1/2) The number of OTSC deployments, n 1 92.3 (36/39) 84.6 (33/39) 2 100 (12/12) 100 (12/12) 3 80 (4/5) 80 (4/5)
Table 4 Outcomes of the simple suction and Twin Grasper methods n (%)
Parameters SS-method (n = 14) TG-method (n = 42) P valueTechnical success rate 14 (100) 37 (88.1) 0.1761 Clinical success rate 11 (78.6) 37 (88.1) 0.3781 Procedure time, median (range), min 5 (1-16) 12 (3-36) in 37 successful cases 0.00042 Complications 0 (0) 1 (2.4) 0.5871
Table 5 Results of the technical and clinical success rates of the simple suction- and Twin Grasper-groups for each parameter
Parameters Technical success rate Clinical success rate SS (n = 14) TG (n = 42) P value1 SS (n = 14) TG (n = 42) P value1 Indication Refractory bleeding 100 (7/7) 81.8 (9/11) 0.2315 85.7 (6/7) 81.8 (9/11) 0.8288 Leak 100 (2/2) 92 (23/25) 0.6776 50 (1/2) 92 (23/25) 0.0690 Fistula 100 (5/5) 83.3 (5/6) 0.3384 80 (4/5) 83.3 (5/6) 0.8865 Location Upper GI tract 100 (8/8) 85.3 (29/34) 0.8725 75 (6/8) 85.3 (29/34) 0.8725 Lower GI tract 100 (6/6) 100 (8/8) 83.3 (5/6) 100 (8/8) 0.2308 Maximum defect size (D), mm D ≤ 10 100 (14/14) 100 (9/9) 78.6 (11/14) 100 (9/9) 0.1364 10 < D ≤ 20 - 88.9 (8/9) - - 88.9 (8/9) - 20 < D - 83.3 (20/24) - - 83.3 (20/24) - Duration since onset, % (n ) Immediate ≤ 1 d 100 (3/3) 95.5 (21/22) 0.6994 100 (3/3) 95.5 (21/22) 0.6994 1 < Acute ≤ 7 d 100 (3/3) 87.5 (7/8) 0.1247 66.7 (2/3) 87.5 (7/8) 0.1247 Chronic > 7 d 100 (8/8) 75 (9/12) 0.1250 75 (6/8) 75 (9/12) 1.0000
Table 6 Comparison of the clinical success rates for the combined parameters in each indication
Clinical success rate Indications Refractory bleeding (n = 18) Leak (n = 27) Fistula (n = 11) Combined parameters SS (n = 7) TG (n = 11) SS (n = 2) TG (n = 25) SS (n = 5) TG (n = 6) D ≤ 10, Immediate 100% 100% - 100% - - D ≤ 10, Acute 100% - 50% 100% - - D ≤ 10, Chronic 66.7% 100% - - 80% 100% 10 < D ≤ 20, Immediate - 100% - 66.7% - - 10 < D ≤ 20, Acute - 100% - 100% - - 10 < D ≤ 20, Chronic - 100% - - - 100% D > 20, Immediate - 100% - 100% - - D > 20, Acute - - - 75% - - D > 20, Chronic - 33.3% - - - 50%
Table 7 Details of over-the-scope clips clinical failure cases (n = 8)
Indication Max. defect size, mm Cause, comorbidity Location Prior therapy Duration since onset Technical success Technical or clinical failure factor Additional therapy Clinical outcome Refractory bleeding 8 Ileal ulcer bleeding due to steroid treatment for myelodysplastic syndrome Terminal ileum EI (hemoclips and coagulation) Chronic Yes Suspicion of angiogenesis due to steroid in particular circumstances Elective surgery Survival Refractory bleeding 20 Peptic ulcer, Refractory neurogenic disease Stomach (body) EI (coagulation) Chronic No Fibrotic tissue Retry of EI Survival Refractory bleeding 50 Peptic ulcer, Advanced gallbladder carcinoma Stomach (body) EI (coagulation) Chronic No Fibrotic tissue Retry of EI Survival Leak 7 Anastomotic leakage after surgery for gastric cancer Esophageal gastric junction None Acute Yes Leakage by mucosal suture (suspected) Elective surgery Survival Leak 21 Perforation during ERCP Duodenal 2nd portion None Immediate No Inability of platform Emergency surgery Survival Leak 50 Delayed perforation after ESD Stomach (prepyrolus) None Acute No Location with narrow lumen Elective surgery Survival Fistula 8 Interventional EUS Gastric (prepyrolus)- pseudopancreatic cyst None Chronic Yes Leakage by mucosal suture (suspected) Elective surgery Survival Fistula 22 Radiation for esophageal carcinoma Gastric tube-trachea Bronchial embolization Chronic No Fibrotic tissue Elective surgery Survival
Table 8 Current clinical outcomes of over-the-scope clips for each indication
Ref .Year Country Patients (n ) Overall clinical success rate, (success/ total) Mean defect size (mm) Described data of suction method Complications, n (%) Refractory bleeding Leaks and/or perforations Fistula Others Total Albert et al [20 ] 2011 Germany 19 57.1 (4/7) 87.5 (7/8) 25 (1/4) - 63.2 Unknown Unknown 0 Surace et al [21 ] 2011 France, Monaco 19 - - 74 (14/19) - 73.7 Unknown Unknown 1 (5) Kirschniak et al [22 ] 2011 Germany 50 92.6 (25/27) 100 (11/11) 37.5 (3/8) 100 (4/4) 86 6 Unknown 0 Baron et al [19 ] 2012 United States 45 100 (7/7) 62.5 (5/8) 67.9 (19/28) 50 (1/2) 71 Unknown TG: 8 cases AC: 17 cases 2 (4.4) Manta et al [23 ] 2013 Italy 30 90 (27/30) - - - 90 Unknown Unknown 0 Haito-Chavez et al [15 ] 2014 International2 188 - Leaks 73.3 (22/30), 21 Perforations 90 (36/40), 81 42.9 (39/91), 171 - 60.2 Leaks: 8 Perforations: 7 Fistula: 5 Use of TG and/or AC, 50% (70/140 cases)3 0 Law et al [24 ] 2014 United States 47 - - 53 (25/47) - 53 Unknown Unknown 0 Sulz et al [25 ] 2014 Switzerland 21 100 (1/1) 66.7 (4/6) 63.6 (7/11) 100 (3/3) 71.4 8 SS:4 100% (10/10) TG:100% (1/1) AC: 87.5% (7/8) TG + AC: 0% (0/1) 0 Mercky et al [26 ] 2015 France, Monaco 30 - - 53 (16/30) - 53 7.2 SS: 17 procedures TG: 9 procedures AC: 5 procedures 4 (13.3) Our study 2016 Japan 58 83.3 (15/18) 85.7 (24/28) 83.3 (10/12) - 84.5 19.6 CSR SS4 : 78.6% (11/14) TG: 88.1% (37/42) AC: 50% (1/2) 1 (1.8) Total 507 87.8 (79/90) 83.2 (109/131) 53.0 (133/251) 88.9 (8/9) 68.4 (329/481) 8/481 (1.66)
Citation: Kobara H, Mori H, Fujihara S, Nishiyama N, Chiyo T, Yamada T, Fujiwara M, Okano K, Suzuki Y, Murota M, Ikeda Y, Oryu M, AboEllail M, Masaki T. Outcomes of gastrointestinal defect closure with an over-the-scope clip system in a multicenter experience: An analysis of a successful suction method. World J Gastroenterol 2017; 23(9): 1645-1656
URL: https://www.wjgnet.com/1007-9327/full/v23/i9/1645.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i9.1645